Pérez Aliaga Ana Isabel, Ayerra Irene, Cardoso Marcia, Puente Fernando, Aranda Alfonso, Domingo José María, Plantagenet-Whyte Rosa
Blood and Tissues Bank of Aragón (BTBA), Zaragoza, Spain.
Hemotic, Olite, Spain.
Vox Sang. 2025 Jan;120(1):32-38. doi: 10.1111/vox.13752. Epub 2024 Oct 23.
Blood establishments face environmental, financial, demographic and societal challenges that may impair sustainable blood supply to patients. This study presents the technologies (devices and software) assembled in a global ecosystem implemented by the Blood and Tissue Bank of Aragón (BTBA), Spain, over the last decade to overcome these challenges.
Descriptive yearly activity data (2013-2023) of BTBA were retrospectively collected to evaluate the impact of different technologies on blood processing efficiency, focusing on the production of blood components (red blood cell concentrates [RCCs], platelet concentrates [PCs]) and plasma. Operator satisfaction about the technologies introduced in daily routine work was also monitored.
Between 2013 and 2023, the annual production decreased by 16.0% for RCCs and increased by 13.3% for PCs. From 2020, all PCs were treated with pathogen reduction technology, and no inventory stock-out was reported. The lowest PC expiry rate (0.2%) was observed after the implementation of the software for blood processing and PC stock management. The deployment of this software also improved plasma recovery: on average, an extra plasma volume of 9 mL was collected per donation in 2023 compared to 2015. A survey confirmed staff satisfaction.
The progressive implementation of automated and software-based solutions was key to increasing efficiencies in BTBA. This enabled the optimization of blood processing by maximizing productivity, enhancing traceability, reducing overproduction and wastage and increasing the yield of recovered plasma, while ensuring blood product safety and staff satisfaction.
血液机构面临着环境、财务、人口结构和社会等方面的挑战,这些挑战可能会损害对患者的可持续血液供应。本研究介绍了西班牙阿拉贡血液与组织库(BTBA)在过去十年中为克服这些挑战而在全球生态系统中整合的技术(设备和软件)。
回顾性收集了BTBA 2013 - 2023年的年度描述性活动数据,以评估不同技术对血液处理效率的影响,重点关注血液成分(红细胞浓缩物[RCCs]、血小板浓缩物[PCs])和血浆的生产。还监测了操作人员对日常工作中引入的技术的满意度。
2013年至2023年期间,RCCs的年产量下降了16.0%,而PCs的年产量增长了13.3%。从2020年起,所有PCs均采用了病原体灭活技术,且未报告库存短缺情况。在实施血液处理和PC库存管理软件后,观察到PCs的最低过期率(0.2%)。该软件的应用还提高了血浆回收率:与2015年相比,2023年每次献血平均多采集9毫升血浆。一项调查证实了工作人员的满意度。
逐步实施自动化和基于软件的解决方案是提高BTBA效率的关键。这通过提高生产率、增强可追溯性、减少过量生产和浪费以及提高回收血浆的产量,实现了血液处理的优化,同时确保了血液制品的安全和工作人员的满意度。